| [1] Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med, 2010, 362(4): 329-344.[2] Boulianne GL, Livne-Bar I, Humphreys JM, Liang Y, Lin C, Rogaev E, St George-Hyslop P. Cloning and characterization of the Drosophila presenilin homologue. Neuroreport, 1997, 8(4): 1025-1029.[3] Hong CS, Koo EH. Isolation and characterization of Drosophila presenilin homolog. Neuroreport, 1997, 8(3): 665-668.[4] Ye YH, Fortini ME. Characterization of Drosophila presenilin and its colocalization with notch during development. Mech Dev, 1998, 79(1-2): 199-211.[5] Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Banero I, Pinessi L, Chumakov I, Pollen D, Brookes A, Sanseau A, Sanseau P, Polinsky RJ, Wasco W, da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH. Cloning of a gene bearing missense mutations in early onset familial Alzheimer’s disease. Nature, 1995, 375(6534): 754-760.[6] Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St George-Hyslop PH. Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature, 1995, 376(6543): 775-778.[7] Bergmans BA, De Strooper B. γ-secretases: from cell biology to therapeutic strategies. Lancet Neurol, 2010, 9(2): 215-226.[8] Nowotny P, Gorski SM, Han SW, Philips K, Ray WJ, Nowotny V, Jones CJ, Clark RF, Cagan RL, Goate AM. Posttranslational modification and plasma membrane localization of the Drosophila melanogaster presenilin. Mol Cell Neurosci, 2000, 15(1): 88-98.[9] Dewji NN. Presenilin structure in mechanisms leading to Alzheimer's disease. J Alzheimers Dis, 2006, 10(2-3): 277-290.[10] Doan A, Thinakaran G, Borchelt DR, Slunt HH, Ratovitsky T, Podlisny M, Selkoe DJ, Seeger M, Gandy SE, Price DL, Sisodia SS. Protein topology of presenilin 1. Neuron, 1996, 17(5): 1023-1030.[11] De Strooper B. Aph-1, pen-2, and nicastrin with presenilin generate an active γ-secretase complex. Neuron, 2003, 38(1): 9-12.[12] Parks AL, Curtis D. Presenilin diversifies its portfolio. Trends Genet, 2007, 23(3): 140-150.[13] Baki L, Shioi J, Wen P, Shao ZP, Schwarzman A, Gama-Sosa M, Neve R, Robakis NK. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J, 2004, 23(13): 2586-2596.[14] Link CD. Invertebrate models of Alzheimer’s disease. Genes Brain Behav, 2005, 4(3): 147-156.[15] Woo HN, Park JS, Gwon AR, Arumugam TV, Jo DG. Alzheimer’s disease and notch signaling. Biochem Biophys Res Commun, 2009, 390(4): 1093-1097.[16] Presente A, Boyles RS, Serway CN, de Belle JS, Andres AJ. Notch is required for long-term memory in Drosophila. Proc Natl Acad Sci USA, 2004, 101(6): 1764-1768.[17] Roncarati R, Šestan N, Scheinfeld MH, Berechid BE, Lopez PA, Meucci O, McGlade JC, Rakic P, D'Adamio L. The γ-secretase-generated intracellular domain of β-amyloid precursor protein binds numb and inhibits notch signaling. Proc Natl Acad Sci USA, 2002, 99(10): 7102-7107.[18] Struhl G, Greenwald I. Presenilin is required for activity and nuclear access of notch in Drosophila. Nature, 1999, 398(6727): 522-525.[19] Ray WJ, Yao M, Nowotny P, Mumm J, Zhang WJ, Wu JY, Kopan R, Goate AM. Evidence for a physical interaction between presenilin and notch. Proc Natl Acad Sci USA, 1999, 96(6): 3263-3268.[20] Ye YH, Lukinova N, Fortini M |
